NCT04975711View on ClinicalTrials.gov

Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP2105 to RLD2104 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

July 12, 2021

Primary Completion Date

November 3, 2021

Study Completion Date

November 3, 2021

Conditions
Healthy Volunteer
Interventions
DRUG

HIP2105

Test drug

DRUG

RLD2104

Reference drug

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT04975711 - Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP2105 to RLD2104 in Healthy Volunteers | Biotech Hunter | Biotech Hunter